In summary, cardiac-specific Ndufs1 overexpression could effectively alleviate cardiac dysfunction in the healing phase of MI, which may be attributed to improved mitochondrial function and reduced ROS generation. This evidence concerns the gene NDUFS1 and myocardial infarction.